BlackRock Health Sciences Trust II is a closed-end fund designed to deliver total return and income through a combination of current income, current gains, and long-term capital appreciation. The trust primarily invests at least 80% of its assets in equity securities of companies principally engaged in the health sciences sector, including biotechnology, pharmaceuticals, medical devices, and healthcare services. Additionally, it employs an option writing strategy on a portion of its assets to generate current gains from option premiums, aiming to enhance risk-adjusted returns and provide a consistent income stream to investors. The fund is actively managed by a team of experienced portfolio managers and typically maintains a diversified portfolio with holdings in leading global health sciences companies. BlackRock Health Sciences Trust II plays a notable role in the market by offering targeted exposure to the innovation-driven health sector, balancing opportunities for capital growth with regular income distributions, and utilizing risk management through options strategies.
Earnings calendar coming soon. Subscribe to get notified when BMEZ reports next.
Get earnings alerts →